Identification of potential therapeutic targets from bioinformatics analysis of necroptosis and immune infiltration in acute myocardial infarction
Acute myocardial infarction (AMI) is a serious, deadly disease with a high incidence. However, it remains unclear how necroptosis affects the pathophysiology of AMI. Using bioinformatic analyses, this study investigated necroptosis in AMI. We obtained the GSE66360 dataset related to AMI by the GEO d...
Saved in:
| Published in: | Journal of cardiothoracic surgery Vol. 19; no. 1; pp. 524 - 15 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
BioMed Central Ltd
11-09-2024
BioMed Central BMC |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Acute myocardial infarction (AMI) is a serious, deadly disease with a high incidence. However, it remains unclear how necroptosis affects the pathophysiology of AMI. Using bioinformatic analyses, this study investigated necroptosis in AMI.
We obtained the GSE66360 dataset related to AMI by the GEO database. Venn diagrams were used to identify necroptosis-related differential genes (NRDEGs). The genes with differential expression in AMI were analyzed using gene set enrichment analysis, and a PPI network was established. A transcription factor prediction and enrichment analysis were conducted for the NRDEGs, and the relationships between AMI, NRDEGs, and immune cells were determined. Finally, in the additional dataset, NRDEG expression levels, immune infiltration, and ROC curve analysis were confirmed, and gene expression levels were further verified experimentally.
GSEA revealed that necroptosis pathways were significantly enriched in AMI. We identified 10 NRDEGs, including TNF, TLR4, FTH1 and so on. Enrichment analysis indicated that the NOD-like receptor and NF-kappa B signaling pathways were significantly enriched. Four NRDEGs, FTH1, IFNGR1, STAT3, and TLR4, were identified; however, additional datasets and further experimental validation are required to confirm their roles. In addition, we determined that a high abundance of macrophages and neutrophils prompted AMI development.
In this study, four potential genes that affect the development of AMI through necroptosis (FTH1, IFNGR1, STAT3, and TLR4) were identified. In addition, we found that a high abundance of macrophages and neutrophils affected AMI. This helps determine the pathological mechanism of necroptosis and immune cells that influence AMI and provides a novel strategy for targeted therapy. |
|---|---|
| AbstractList | Acute myocardial infarction (AMI) is a serious, deadly disease with a high incidence. However, it remains unclear how necroptosis affects the pathophysiology of AMI. Using bioinformatic analyses, this study investigated necroptosis in AMI.
We obtained the GSE66360 dataset related to AMI by the GEO database. Venn diagrams were used to identify necroptosis-related differential genes (NRDEGs). The genes with differential expression in AMI were analyzed using gene set enrichment analysis, and a PPI network was established. A transcription factor prediction and enrichment analysis were conducted for the NRDEGs, and the relationships between AMI, NRDEGs, and immune cells were determined. Finally, in the additional dataset, NRDEG expression levels, immune infiltration, and ROC curve analysis were confirmed, and gene expression levels were further verified experimentally.
GSEA revealed that necroptosis pathways were significantly enriched in AMI. We identified 10 NRDEGs, including TNF, TLR4, FTH1 and so on. Enrichment analysis indicated that the NOD-like receptor and NF-kappa B signaling pathways were significantly enriched. Four NRDEGs, FTH1, IFNGR1, STAT3, and TLR4, were identified; however, additional datasets and further experimental validation are required to confirm their roles. In addition, we determined that a high abundance of macrophages and neutrophils prompted AMI development.
In this study, four potential genes that affect the development of AMI through necroptosis (FTH1, IFNGR1, STAT3, and TLR4) were identified. In addition, we found that a high abundance of macrophages and neutrophils affected AMI. This helps determine the pathological mechanism of necroptosis and immune cells that influence AMI and provides a novel strategy for targeted therapy. Abstract Introduction Acute myocardial infarction (AMI) is a serious, deadly disease with a high incidence. However, it remains unclear how necroptosis affects the pathophysiology of AMI. Using bioinformatic analyses, this study investigated necroptosis in AMI. Methods We obtained the GSE66360 dataset related to AMI by the GEO database. Venn diagrams were used to identify necroptosis-related differential genes (NRDEGs). The genes with differential expression in AMI were analyzed using gene set enrichment analysis, and a PPI network was established. A transcription factor prediction and enrichment analysis were conducted for the NRDEGs, and the relationships between AMI, NRDEGs, and immune cells were determined. Finally, in the additional dataset, NRDEG expression levels, immune infiltration, and ROC curve analysis were confirmed, and gene expression levels were further verified experimentally. Results GSEA revealed that necroptosis pathways were significantly enriched in AMI. We identified 10 NRDEGs, including TNF, TLR4, FTH1 and so on. Enrichment analysis indicated that the NOD-like receptor and NF-kappa B signaling pathways were significantly enriched. Four NRDEGs, FTH1, IFNGR1, STAT3, and TLR4, were identified; however, additional datasets and further experimental validation are required to confirm their roles. In addition, we determined that a high abundance of macrophages and neutrophils prompted AMI development. Conclusions In this study, four potential genes that affect the development of AMI through necroptosis (FTH1, IFNGR1, STAT3, and TLR4) were identified. In addition, we found that a high abundance of macrophages and neutrophils affected AMI. This helps determine the pathological mechanism of necroptosis and immune cells that influence AMI and provides a novel strategy for targeted therapy. Acute myocardial infarction (AMI) is a serious, deadly disease with a high incidence. However, it remains unclear how necroptosis affects the pathophysiology of AMI. Using bioinformatic analyses, this study investigated necroptosis in AMI.INTRODUCTIONAcute myocardial infarction (AMI) is a serious, deadly disease with a high incidence. However, it remains unclear how necroptosis affects the pathophysiology of AMI. Using bioinformatic analyses, this study investigated necroptosis in AMI.We obtained the GSE66360 dataset related to AMI by the GEO database. Venn diagrams were used to identify necroptosis-related differential genes (NRDEGs). The genes with differential expression in AMI were analyzed using gene set enrichment analysis, and a PPI network was established. A transcription factor prediction and enrichment analysis were conducted for the NRDEGs, and the relationships between AMI, NRDEGs, and immune cells were determined. Finally, in the additional dataset, NRDEG expression levels, immune infiltration, and ROC curve analysis were confirmed, and gene expression levels were further verified experimentally.METHODSWe obtained the GSE66360 dataset related to AMI by the GEO database. Venn diagrams were used to identify necroptosis-related differential genes (NRDEGs). The genes with differential expression in AMI were analyzed using gene set enrichment analysis, and a PPI network was established. A transcription factor prediction and enrichment analysis were conducted for the NRDEGs, and the relationships between AMI, NRDEGs, and immune cells were determined. Finally, in the additional dataset, NRDEG expression levels, immune infiltration, and ROC curve analysis were confirmed, and gene expression levels were further verified experimentally.GSEA revealed that necroptosis pathways were significantly enriched in AMI. We identified 10 NRDEGs, including TNF, TLR4, FTH1 and so on. Enrichment analysis indicated that the NOD-like receptor and NF-kappa B signaling pathways were significantly enriched. Four NRDEGs, FTH1, IFNGR1, STAT3, and TLR4, were identified; however, additional datasets and further experimental validation are required to confirm their roles. In addition, we determined that a high abundance of macrophages and neutrophils prompted AMI development.RESULTSGSEA revealed that necroptosis pathways were significantly enriched in AMI. We identified 10 NRDEGs, including TNF, TLR4, FTH1 and so on. Enrichment analysis indicated that the NOD-like receptor and NF-kappa B signaling pathways were significantly enriched. Four NRDEGs, FTH1, IFNGR1, STAT3, and TLR4, were identified; however, additional datasets and further experimental validation are required to confirm their roles. In addition, we determined that a high abundance of macrophages and neutrophils prompted AMI development.In this study, four potential genes that affect the development of AMI through necroptosis (FTH1, IFNGR1, STAT3, and TLR4) were identified. In addition, we found that a high abundance of macrophages and neutrophils affected AMI. This helps determine the pathological mechanism of necroptosis and immune cells that influence AMI and provides a novel strategy for targeted therapy.CONCLUSIONSIn this study, four potential genes that affect the development of AMI through necroptosis (FTH1, IFNGR1, STAT3, and TLR4) were identified. In addition, we found that a high abundance of macrophages and neutrophils affected AMI. This helps determine the pathological mechanism of necroptosis and immune cells that influence AMI and provides a novel strategy for targeted therapy. Introduction Acute myocardial infarction (AMI) is a serious, deadly disease with a high incidence. However, it remains unclear how necroptosis affects the pathophysiology of AMI. Using bioinformatic analyses, this study investigated necroptosis in AMI. Methods We obtained the GSE66360 dataset related to AMI by the GEO database. Venn diagrams were used to identify necroptosis-related differential genes (NRDEGs). The genes with differential expression in AMI were analyzed using gene set enrichment analysis, and a PPI network was established. A transcription factor prediction and enrichment analysis were conducted for the NRDEGs, and the relationships between AMI, NRDEGs, and immune cells were determined. Finally, in the additional dataset, NRDEG expression levels, immune infiltration, and ROC curve analysis were confirmed, and gene expression levels were further verified experimentally. Results GSEA revealed that necroptosis pathways were significantly enriched in AMI. We identified 10 NRDEGs, including TNF, TLR4, FTH1 and so on. Enrichment analysis indicated that the NOD-like receptor and NF-kappa B signaling pathways were significantly enriched. Four NRDEGs, FTH1, IFNGR1, STAT3, and TLR4, were identified; however, additional datasets and further experimental validation are required to confirm their roles. In addition, we determined that a high abundance of macrophages and neutrophils prompted AMI development. Conclusions In this study, four potential genes that affect the development of AMI through necroptosis (FTH1, IFNGR1, STAT3, and TLR4) were identified. In addition, we found that a high abundance of macrophages and neutrophils affected AMI. This helps determine the pathological mechanism of necroptosis and immune cells that influence AMI and provides a novel strategy for targeted therapy. Keywords: Acute myocardial infarction, Bioinformatics analyses, Immune Infiltration, Necroptosis, Targeted therapy Acute myocardial infarction (AMI) is a serious, deadly disease with a high incidence. However, it remains unclear how necroptosis affects the pathophysiology of AMI. Using bioinformatic analyses, this study investigated necroptosis in AMI. We obtained the GSE66360 dataset related to AMI by the GEO database. Venn diagrams were used to identify necroptosis-related differential genes (NRDEGs). The genes with differential expression in AMI were analyzed using gene set enrichment analysis, and a PPI network was established. A transcription factor prediction and enrichment analysis were conducted for the NRDEGs, and the relationships between AMI, NRDEGs, and immune cells were determined. Finally, in the additional dataset, NRDEG expression levels, immune infiltration, and ROC curve analysis were confirmed, and gene expression levels were further verified experimentally. GSEA revealed that necroptosis pathways were significantly enriched in AMI. We identified 10 NRDEGs, including TNF, TLR4, FTH1 and so on. Enrichment analysis indicated that the NOD-like receptor and NF-kappa B signaling pathways were significantly enriched. Four NRDEGs, FTH1, IFNGR1, STAT3, and TLR4, were identified; however, additional datasets and further experimental validation are required to confirm their roles. In addition, we determined that a high abundance of macrophages and neutrophils prompted AMI development. In this study, four potential genes that affect the development of AMI through necroptosis (FTH1, IFNGR1, STAT3, and TLR4) were identified. In addition, we found that a high abundance of macrophages and neutrophils affected AMI. This helps determine the pathological mechanism of necroptosis and immune cells that influence AMI and provides a novel strategy for targeted therapy. |
| ArticleNumber | 524 |
| Audience | Academic |
| Author | Li, Jiakang Qiu, Zhihuang Chen, Liangwan Chen, Keyuan Xie, Linfeng Zarif, Mohammad Zhang, Zhaofeng Chai, Tianci Ma, Likang Wu, Qingsong |
| Author_xml | – sequence: 1 givenname: Likang surname: Ma fullname: Ma, Likang organization: Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China – sequence: 2 givenname: Keyuan surname: Chen fullname: Chen, Keyuan organization: Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China – sequence: 3 givenname: Jiakang surname: Li fullname: Li, Jiakang organization: The Key Laboratory of Fujian Province Universities on Ion Channel and Signal Transduction in Cardiovascular Diseases, Department of Physiology and Pathophysiology, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China – sequence: 4 givenname: Linfeng surname: Xie fullname: Xie, Linfeng organization: Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China – sequence: 5 givenname: Zhaofeng surname: Zhang fullname: Zhang, Zhaofeng organization: Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China – sequence: 6 givenname: Mohammad surname: Zarif fullname: Zarif, Mohammad organization: Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China – sequence: 7 givenname: Tianci surname: Chai fullname: Chai, Tianci organization: Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China – sequence: 8 givenname: Qingsong surname: Wu fullname: Wu, Qingsong organization: Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China – sequence: 9 givenname: Liangwan surname: Chen fullname: Chen, Liangwan email: chenliangwan@tom.com, chenliangwan@tom.com organization: Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China. chenliangwan@tom.com – sequence: 10 givenname: Zhihuang surname: Qiu fullname: Qiu, Zhihuang email: qzhflm@126.com, qzhflm@126.com organization: Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China. qzhflm@126.com |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39261934$$D View this record in MEDLINE/PubMed |
| BookMark | eNptUk1v3CAQtapUzUf7B3qokHrpxSkw2IZTFUVNulKkXtozYvnYENmwBVxp_0Z_cXGcRlmp4gAM772ZYd55cxJisE3znuBLQnj_ORPARLSYshYDBt72r5ozMjDRcizwyYvzaXOe8wPGrAPcvWlOQdCeCGBnzZ-NsaF457UqPgYUHdrHsoTUiMq9TWpv5-I1KirtbMnIpTihrY8-uJimStIZqaDGQ_Z5YQerU9yXuFxVMMhP0xwsqnA_lrQm8QEpPReLpkPUKpklVwWopJfnt81rp8Zs3z3tF83Pm68_rr-1d99vN9dXd61mZCitE9C5gWyd29qBYE5YR8FQ7LadHTBo6rhmlvbMdABOYGwcYRQ44UJ00Gu4aDarronqQe6Tn1Q6yKi8fAzEtJMq1f5GK4kBzTTtiNGEsZ7zvgcQFowSnXBDX7W-rFr7eTtZo-sHJjUeiR6_BH8vd_G3JAR4HQRUhU9PCin-mm0ucvJZ23FUwcY5SyAYGOMDFhX6cYXuVK1tGUSV1AtcXnHMGRWcdhV1-R9UXcZOXlcn1YHYYwJdCXWAOSfrnssnWC6Gk6vhZDWcfDScXBr_8LLxZ8o_h8FfLM3Vcg |
| Cites_doi | 10.7150/thno.51390 10.1186/s12974-020-01850-0 10.1016/j.yjmcc.2021.09.010 10.1016/S0140-6736(04)16632-4 10.1080/21655979.2021.1937906 10.1002/advs.201902880 10.1161/01.CIR.0000112575.66565.84 10.3389/fcvm.2020.586871 10.1093/eurheartj/ehx393 10.1126/sciadv.1600224 10.1161/CIR.0000000000000757 10.1093/eurheartj/ehi455 10.3390/ijms21218174 10.1089/omi.2011.0118 10.3390/ijms23095214 10.3390/ijms23031281 10.1093/nar/gkaa1074 10.1016/j.pharmthera.2008.08.002 10.1016/j.thromres.2017.07.031 10.1093/nar/gky311 10.1093/nar/gkac194 10.1172/jci.insight.128834 10.1056/NEJMra1310050 10.1126/sciadv.abj2797 10.1038/s41419-018-1189-2 10.1016/S0092-8674(02)00701-8 10.1016/S0891-5849(02)00842-0 10.1093/cvr/cvu146 10.3390/cells10010051 10.1161/JAHA.122.028198 10.1101/gr.1239303 10.1161/01.RES.0000130526.20854.fa 10.3389/fphar.2018.00721 10.1038/nm.4017 10.1038/srep11432 |
| ContentType | Journal Article |
| Copyright | 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. The Author(s) 2024 2024 |
| Copyright_xml | – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: The Author(s) 2024 2024 |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.1186/s13019-024-03038-6 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1749-8090 |
| EndPage | 15 |
| ExternalDocumentID | oai_doaj_org_article_1d3c4c251dc14468866339e3da959f76 A808429825 10_1186_s13019_024_03038_6 39261934 |
| Genre | Journal Article |
| GeographicLocations | Taiwan |
| GeographicLocations_xml | – name: Taiwan |
| GrantInformation_xml | – fundername: Fujian Provincial Special Reserve Talents Fund grantid: 2021-25 |
| GroupedDBID | --- -5E -5G -A0 -BR 0R~ 29K 2WC 3V. 53G 5GY 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF D-I DIK DU5 E3Z EBD EBLON EBS ECM EIF EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M~E NPM O5R O5S OK1 P2P P6G PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW ~8M AAYXX CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c417t-f935f71bffbe710814523d20fb5e703c2f8c4e264d533f900df142381899536c3 |
| IEDL.DBID | RPM |
| ISSN | 1749-8090 |
| IngestDate | Tue Oct 22 14:55:39 EDT 2024 Thu Sep 12 05:40:26 EDT 2024 Sat Oct 26 04:05:41 EDT 2024 Thu Sep 19 02:07:45 EDT 2024 Tue Sep 17 03:58:51 EDT 2024 Wed Sep 18 12:55:48 EDT 2024 Sat Nov 02 12:20:49 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Bioinformatics analyses, Immune Infiltration Acute myocardial infarction Necroptosis Targeted therapy |
| Language | English |
| License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c417t-f935f71bffbe710814523d20fb5e703c2f8c4e264d533f900df142381899536c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11389343/ |
| PMID | 39261934 |
| PQID | 3103448709 |
| PQPubID | 23479 |
| PageCount | 15 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_1d3c4c251dc14468866339e3da959f76 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11389343 proquest_miscellaneous_3103448709 gale_infotracmisc_A808429825 gale_infotracacademiconefile_A808429825 crossref_primary_10_1186_s13019_024_03038_6 pubmed_primary_39261934 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-09-11 |
| PublicationDateYYYYMMDD | 2024-09-11 |
| PublicationDate_xml | – month: 09 year: 2024 text: 2024-09-11 day: 11 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Journal of cardiothoracic surgery |
| PublicationTitleAlternate | J Cardiothorac Surg |
| PublicationYear | 2024 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | W Wang (3038_CR38) 2023; 33 F Liu (3038_CR39) 2022; 2022 D Karunakaran (3038_CR14) 2016; 2 B Ibanez (3038_CR2) 2018; 39 A Chakraborty (3038_CR13) 2022; 163 M Luedde (3038_CR10) 2014; 103 S Zhe-Wei (3038_CR11) 2018; 9 A Mathur (3038_CR6) 2004; 364 BT Sherman (3038_CR21) 2022; 50 RY Luo (3038_CR34) 2020; 17 L Galiuto (3038_CR5) 2000; 1 WY Shen (3038_CR36) 2022; 8 3038_CR33 3038_CR12 3038_CR17 3038_CR15 3038_CR37 J Oyama (3038_CR32) 2004; 109 M Cao (3038_CR30) 2018; 9 KE Hally (3038_CR31) 2017; 158 G Yu (3038_CR20) 2012; 16 YR Miao (3038_CR26) 2020; 7 K Boengler (3038_CR29) 2008; 120 P Shannon (3038_CR23) 2003; 13 P Arosio (3038_CR27) 2002; 33 ZL Hu (3038_CR35) 2021; 11 M Nian (3038_CR4) 2004; 94 D Szklarczyk (3038_CR22) 2021; 49 3038_CR8 Y Xie (3038_CR18) 2021; 12 T Zhang (3038_CR9) 2016; 22 A Linkermann (3038_CR7) 2014; 370 SS Virani (3038_CR1) 2020; 141 XH Wang (3038_CR16) 2020; 34 E Zhao (3038_CR19) 2020; 7 J.J O’Shea (3038_CR28) 2002; 109 J Herrmann (3038_CR3) 2005; 26 M Franz (3038_CR24) 2018; 46 H Han (3038_CR25) 2015; 5 |
| References_xml | – volume: 11 start-page: 715 issue: 2 year: 2021 ident: 3038_CR35 publication-title: Theranostics doi: 10.7150/thno.51390 contributor: fullname: ZL Hu – volume: 17 start-page: 169 issue: 1 year: 2020 ident: 3038_CR34 publication-title: J Neuroinflammation doi: 10.1186/s12974-020-01850-0 contributor: fullname: RY Luo – volume: 163 start-page: 67 year: 2022 ident: 3038_CR13 publication-title: J Mol Cell Cardiol doi: 10.1016/j.yjmcc.2021.09.010 contributor: fullname: A Chakraborty – volume: 364 start-page: 183 issue: 9429 year: 2004 ident: 3038_CR6 publication-title: Lancet doi: 10.1016/S0140-6736(04)16632-4 contributor: fullname: A Mathur – volume: 2022 start-page: p6184802 year: 2022 ident: 3038_CR39 publication-title: Oxid Med Cell Longev contributor: fullname: F Liu – volume: 12 start-page: 2890 issue: 1 year: 2021 ident: 3038_CR18 publication-title: Bioengineered doi: 10.1080/21655979.2021.1937906 contributor: fullname: Y Xie – volume: 7 start-page: 1902880 issue: 7 year: 2020 ident: 3038_CR26 publication-title: Adv Sci (Weinh) doi: 10.1002/advs.201902880 contributor: fullname: YR Miao – volume: 109 start-page: 784 issue: 6 year: 2004 ident: 3038_CR32 publication-title: Circulation doi: 10.1161/01.CIR.0000112575.66565.84 contributor: fullname: J Oyama – volume: 33 start-page: 010702 issue: 1 year: 2023 ident: 3038_CR38 publication-title: Biochem Med (Zagreb) contributor: fullname: W Wang – volume: 7 start-page: 586871 year: 2020 ident: 3038_CR19 publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2020.586871 contributor: fullname: E Zhao – volume: 39 start-page: 119 issue: 2 year: 2018 ident: 3038_CR2 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx393 contributor: fullname: B Ibanez – volume: 2 start-page: e1600224 issue: 7 year: 2016 ident: 3038_CR14 publication-title: Sci Adv doi: 10.1126/sciadv.1600224 contributor: fullname: D Karunakaran – volume: 141 start-page: e139 issue: 9 year: 2020 ident: 3038_CR1 publication-title: Circulation doi: 10.1161/CIR.0000000000000757 contributor: fullname: SS Virani – volume: 26 start-page: 2493 issue: 23 year: 2005 ident: 3038_CR3 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehi455 contributor: fullname: J Herrmann – ident: 3038_CR12 doi: 10.3390/ijms21218174 – volume: 16 start-page: 284 issue: 5 year: 2012 ident: 3038_CR20 publication-title: Omics doi: 10.1089/omi.2011.0118 contributor: fullname: G Yu – ident: 3038_CR15 doi: 10.3390/ijms23095214 – ident: 3038_CR17 doi: 10.3390/ijms23031281 – volume: 49 start-page: D605 issue: D1 year: 2021 ident: 3038_CR22 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkaa1074 contributor: fullname: D Szklarczyk – volume: 120 start-page: 172 issue: 2 year: 2008 ident: 3038_CR29 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2008.08.002 contributor: fullname: K Boengler – volume: 158 start-page: 8 year: 2017 ident: 3038_CR31 publication-title: Thromb Res doi: 10.1016/j.thromres.2017.07.031 contributor: fullname: KE Hally – volume: 34 start-page: 1763 issue: 5 year: 2020 ident: 3038_CR16 publication-title: J Biol Regul Homeost Agents contributor: fullname: XH Wang – volume: 46 start-page: W60 issue: W1 year: 2018 ident: 3038_CR24 publication-title: Nucleic Acids Res doi: 10.1093/nar/gky311 contributor: fullname: M Franz – volume: 50 start-page: W216 issue: W1 year: 2022 ident: 3038_CR21 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkac194 contributor: fullname: BT Sherman – ident: 3038_CR8 doi: 10.1172/jci.insight.128834 – volume: 370 start-page: 455 issue: 5 year: 2014 ident: 3038_CR7 publication-title: Necroptosis N Engl J Med doi: 10.1056/NEJMra1310050 contributor: fullname: A Linkermann – volume: 1 start-page: 108 issue: 2 year: 2000 ident: 3038_CR5 publication-title: Ital Heart J contributor: fullname: L Galiuto – volume: 8 start-page: eabj2797 issue: 3 year: 2022 ident: 3038_CR36 publication-title: Sci Adv doi: 10.1126/sciadv.abj2797 contributor: fullname: WY Shen – volume: 9 start-page: 1140 issue: 12 year: 2018 ident: 3038_CR30 publication-title: Cell Death Dis doi: 10.1038/s41419-018-1189-2 contributor: fullname: M Cao – volume: 109 start-page: S121 issue: Suppl year: 2002 ident: 3038_CR28 publication-title: Cell doi: 10.1016/S0092-8674(02)00701-8 contributor: fullname: J.J O’Shea – volume: 33 start-page: 457 issue: 4 year: 2002 ident: 3038_CR27 publication-title: Free Radic Biol Med doi: 10.1016/S0891-5849(02)00842-0 contributor: fullname: P Arosio – volume: 103 start-page: 206 issue: 2 year: 2014 ident: 3038_CR10 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvu146 contributor: fullname: M Luedde – ident: 3038_CR33 doi: 10.3390/cells10010051 – ident: 3038_CR37 doi: 10.1161/JAHA.122.028198 – volume: 13 start-page: 2498 issue: 11 year: 2003 ident: 3038_CR23 publication-title: Genome Res doi: 10.1101/gr.1239303 contributor: fullname: P Shannon – volume: 94 start-page: 1543 issue: 12 year: 2004 ident: 3038_CR4 publication-title: Circ Res doi: 10.1161/01.RES.0000130526.20854.fa contributor: fullname: M Nian – volume: 9 start-page: 721 year: 2018 ident: 3038_CR11 publication-title: Front Pharmacol doi: 10.3389/fphar.2018.00721 contributor: fullname: S Zhe-Wei – volume: 22 start-page: 175 issue: 2 year: 2016 ident: 3038_CR9 publication-title: Nat Med doi: 10.1038/nm.4017 contributor: fullname: T Zhang – volume: 5 start-page: 11432 year: 2015 ident: 3038_CR25 publication-title: Sci Rep doi: 10.1038/srep11432 contributor: fullname: H Han |
| SSID | ssj0045305 |
| Score | 2.382185 |
| Snippet | Acute myocardial infarction (AMI) is a serious, deadly disease with a high incidence. However, it remains unclear how necroptosis affects the pathophysiology... Introduction Acute myocardial infarction (AMI) is a serious, deadly disease with a high incidence. However, it remains unclear how necroptosis affects the... Abstract Introduction Acute myocardial infarction (AMI) is a serious, deadly disease with a high incidence. However, it remains unclear how necroptosis affects... |
| SourceID | doaj pubmedcentral proquest gale crossref pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 524 |
| SubjectTerms | Acute myocardial infarction Bioinformatics analyses, Immune Infiltration Computational Biology Genes Genetic transcription Health aspects Heart attack Humans Myocardial Infarction - genetics Myocardial Infarction - immunology Myocardial Infarction - pathology Necroptosis Necroptosis - genetics Necroptosis - physiology Targeted therapy |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07j9QwEB7BVTSIE6_AHTISEgWyLo6dxC4PuNNVNIBEZzl-iJWO5MRmC_4Gv5gZO7vaiIKG0vFYcmY-e2YSz2eAN4MI2ongedebyFVSgRvXdTwQ-VbTBxEyXdPN5_7TN_3ximhyDld90ZmwQg9cFHeBwl559MLBU-qiNbpIaaIMzrQm9YVsu9b7ZKrswapFGO9LZHR3scWdmop1GsUR1LjEu5Ubymz9f-_JR05pfWDyyANdP4KHS-jILsuUT-FeHB_D71Jpm5ZPb2xK7G6a6RGKHhVXsXLke8uonoQNm2lhTCWWZuYWZhIaPUa61GueqOnGwDZUQBIZim9uF4pdbDDnd3NkP36hKySI3ZIArhnqfgJfr6--fLjhyz0L3CvRzzwZ2aZeDCkNEQMOLRRmp6Gp09BG3BB8k7RXESOngLFhMnUdklDZ1Rv6-evlUzgZpzE-BzZoHINRBwZuSoXGOSGGIGM_GNWqIHUF7_Zqt3eFTsPmNER3thjJopFsNpLtKnhPljlIEhV2foAAsQtA7L8AUsFbsqsltaKavFvqDnDCRH1lL3Wt0SljplzB2UoSF5pfdb_eI8NSF51OG-O021q6qw3T3L42FTwrSDnMGeNPzFGlqkCvMLR6qXXPuPmeeb4F_USWSr74H2p4CQ-ajH_DhTiDk_nnLp7D_W3YvcpL5w89Hx7y priority: 102 providerName: Directory of Open Access Journals |
| Title | Identification of potential therapeutic targets from bioinformatics analysis of necroptosis and immune infiltration in acute myocardial infarction |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39261934 https://www.proquest.com/docview/3103448709 https://pubmed.ncbi.nlm.nih.gov/PMC11389343 https://doaj.org/article/1d3c4c251dc14468866339e3da959f76 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbYnrggEK_QUhkJiQNyN46dxD6W0qoXEBIgcbMcPyDSbrLqZg_8DX4xM05SbcSNY-Jx5Hg-e2aSmc-EvG24V5Z7x6paByaj9EzbqmIeybeK2nOf6Jpuv9aff6iP10iTU821MClp3zXtRbfZXnTtr5Rbudu69Zwntv7y6Yrj3zUhxXpFVuAczjH6uP_KEiA8l8eoar2HXRoLdQrJANCwvKuFCUpM_f_ux0cGaZkseWR9bh6TR5PbSC_H4T0hD0L3lPwZq2zj9NmN9pHu-gFvgehRYRUd0733FGtJaNP2E1sqMjRTO7GSYO8u4IFeQ4-XtvO0xeKRQEG83Uz0unBBrTsMgW5_gxlEeG1QANYLNj8j32-uv13dsumMBeYkrwcWtShjzZsYmwDOhuISIlNf5LEpA2wGrojKyQBekwe_MOo895HLZOY1_vh14jk56fouvCS0UdAHPA5w2qT0hbWcN16EutGylF6ojLyfp93sRioNk0IQVZlRSQaUZJKSTJWRD6iZe0mkwU43-rufZgKDASQ56cBF8w7jWqXAfxI6CG91qWMND3mHejU4rTBNzk41BzBgpL0ylypXYJAhSs7I2UISFplbNL-ZkWGwCTPTutAf9gbPaYMQt851Rl6MSLkfM_ieEJ8KmRG1wNDipZYtAPnE8T1D_NX_dz0lD4uEes04PyMnw90hvCarvT-cpy8P52nZ_AUQ8B_5 |
| link.rule.ids | 230,315,729,782,786,866,887,2108,27935,27936,53803,53805 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZoOcClgHg0tAUjIXFA6caxk9jHtrRaRFshUSRuVuIHRNpNVt3sgb_RX8yMk1QbcesxmfHKm5mxv0lmPhPysWJWlsyaOC-Ui4UXNlZlnscWybfSwjIb6JrmP4rrX_LLOdLk5GMvTCjaN1V93CyWx039J9RWrpZmNtaJzb5fnTH8usYFn-2QxxCwCR-z9H4FFhk48dggI_PZGtZpbNVJRQwuDQGeTzahwNX__4q8tSVNyyW39p-LZw-d-XOyNyBOetLLX5BHrnlJ7voGXT-8saOtp6u2w1ugutWTRftK8TXFNhRa1e1AtIrkzrQcCE1wdOPwLLCuxcuysbTGvhNHQb1eDMy8cEFLs-kcXf6FHRQ9c4EKEGoofkV-XpzfnM3j4XiG2AhWdLFXPPMFq7yvHOAUyQQktTZNfJU5WEdM6qURDgCXBUjpVZJYz0RACAq_GRv-muw2beP2Ca0kjAGwAnhPCJuWJWOV5a6olMiE5TIin0d76VXPwqFD9iJz3VtXg3V1sK7OI3KKJr3XRAbtcKO9_a0Ha2hwQiMMoDtrMCWWEqAXV47bUmXKF_Ajn9AhND5WeEymHNoVYMLImKVPZCJhL4cEOyKHE02ITzMRfxhdSqMIi9oa127WGo94g-y4SFRE3vQudj9ngK2Q2nIRETlxvsmfmkrA5wI9-Ohjbx8-9D15Mr-5utSXX6-_HZCnaQgdFTN2SHa72407Ijtru3kXou4faXk0wA |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZokRAXHuKVUsBISBxQmjhxEptbabsqAqpKgMTNcvyASLvJqps99G_wi5lxkmojbnBMPF55M994ZpKZz4S8qZkVmlkTl5V0MffcxlKXZWyRfCurLLOBrun8a3XxQ5yeIU3O-6kXJhTtm7o5apero7b5FWor1yuTTHViyeWXE4Zf13KeJ2vrkz1yG4w2LaZMfdiFeQFAnppkRJlsYK_Gdp2MxwBrMPJy5ogCX__fu_KOW5qXTO74oMX9_1n9A3JvjDzp8SDzkNxy7SPye2jU9eObO9p5uu56vAWiO71ZdKgY31BsR6F1042Eq0jyTPVIbIKzW4dngvUdXurW0gb7TxwF8WY5MvTCBdVm2zu6ugZPighdogCYHA4_Jt8XZ99OzuPxmIbYcFb1sZd54StWe187iFcE45Dc2iz1deFgPzGZF4Y7CLwshJZepqn1jIdIQeK3Y5M_Iftt17pnhNYC5kDQAnEf5zbTmrHa5q6qJS-4zUVE3k06U-uBjUOFLEaUatCwAg2roGFVRuQDqvVGEpm0w43u6qcaNaIAjIYbiPKswdRYCAjBculyq2UhfQU_8hZBofCxwmMyemxbgAUjc5Y6FqkAnw6JdkQOZ5Jgp2Y2_HqClcIhLG5rXbfdKDzqDbLkKpUReTrA7GbNEL5CipvziIgZAGd_aj4CuAs04RPODv596ity5_J0oT5_vPj0nNzNgvXImLFDst9fbd0Lsrex25fB8P4A9jE3QA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+potential+therapeutic+targets+from+bioinformatics+analysis+of+necroptosis+and+immune+infiltration+in+acute+myocardial+infarction&rft.jtitle=Journal+of+cardiothoracic+surgery&rft.au=Ma%2C+Likang&rft.au=Chen%2C+Keyuan&rft.au=Li%2C+Jiakang&rft.au=Xie%2C+Linfeng&rft.date=2024-09-11&rft.issn=1749-8090&rft.eissn=1749-8090&rft.volume=19&rft.issue=1&rft.spage=524&rft_id=info:doi/10.1186%2Fs13019-024-03038-6&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1749-8090&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1749-8090&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1749-8090&client=summon |